Possible Inhibitory Effect of Erythropoiesis-Stimulating Agents at the Predialysis Stage on Early-Phase Coronary Events after Hemodialysis Initiation

BACKGROUND: We examined whether the use of erythropoiesis-stimulating agents (ESAs) to correct anemia at the predialysis stage could inhibit early-phase coronary events after hemodialysis initiation. METHODS: We enrolled 242 patients with chronic kidney disease who had received continued medical tre...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cardiorenal Med
Main Authors: Nishimura, Masato, Watanabe, Keitaro, Kitamura, Yuki, Nagashima, Takao, Tokoro, Toshiko, Takatani, Toru, Sato, Nodoka, Yamazaki, Satoru, Hashimoto, Tetsuya, Kobayashi, Hiroyuki, Ono, Toshihiko
Format: Artigo
Jezik:Inglês
Izdano: S. Karger AG 2016
Teme:
Original Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5159719/
https://ncbi.nlm.nih.gov/pubmed/27994599
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000448009
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki